278 related articles for article (PubMed ID: 33721148)
41. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D
Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857
[TBL] [Abstract][Full Text] [Related]
42. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
[TBL] [Abstract][Full Text] [Related]
43. Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.
Houvenaeghel G; Sabatier R; Reyal F; Classe JM; Giard S; Charitansky H; Rouzier R; Faure C; Garbay JR; Daraï E; Hudry D; Gimbergues P; Villet R; Lambaudie E
Br J Cancer; 2016 Oct; 115(9):1024-1031. PubMed ID: 27685443
[TBL] [Abstract][Full Text] [Related]
44. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
[TBL] [Abstract][Full Text] [Related]
45. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
[TBL] [Abstract][Full Text] [Related]
46. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
[TBL] [Abstract][Full Text] [Related]
47. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
[TBL] [Abstract][Full Text] [Related]
48. Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer.
Rovera F; Fachinetti A; Rausei S; Chiappa C; Lavazza M; Arlant V; Marelli M; Boni L; Dionigi G; Dionigi R
Int J Surg; 2013; 11 Suppl 1():S73-8. PubMed ID: 24380559
[TBL] [Abstract][Full Text] [Related]
49. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
[TBL] [Abstract][Full Text] [Related]
50. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
[TBL] [Abstract][Full Text] [Related]
51. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
52. [Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node].
Schmitt C; Bouteille C; Faure C; Mignotte H; Tredan O; Bachelot T; Guastalla JP; Arnaud A; Treilleux I; Carrabin N
Bull Cancer; 2012 Apr; 99(4):463-9. PubMed ID: 22266799
[TBL] [Abstract][Full Text] [Related]
53. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.
Yang Y; He Y; Fan Z; Ouyang T
Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832
[TBL] [Abstract][Full Text] [Related]
54. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
55. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
[TBL] [Abstract][Full Text] [Related]
56. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
[TBL] [Abstract][Full Text] [Related]
57. [Micrometastasis: biological entity and clinical impact?].
Houvenaeghel G; Cohen M; Bannier M; Buttarelli M; Jauffret C; Lambaudie E
Bull Cancer; 2013 Apr; 100(4):351-6. PubMed ID: 23531428
[TBL] [Abstract][Full Text] [Related]
58. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
[TBL] [Abstract][Full Text] [Related]
59. Sentinel node micrometastases in breast cancer: clinical outcome.
Kihara SM; Giblett NA; McNeil C; Crea P
Asia Pac J Clin Oncol; 2010 Dec; 6(4):330-41. PubMed ID: 21114783
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]